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Abstract
Background: SOLAR II is the 2
nd follow-up of a population-based cohort study that follows the participants of ISAAC
Phase Two recruited in Munich and Dresden in 1995/6. A first follow-up study was conducted 2002 and 2003 (SOLAR
I). The aims of SOLAR II were to investigate the course of atopic diseases over puberty taking environmental and
occupational risk factors into account. This paper describes the methods of the 2
nd follow-up carried out from 2007
to 2009 and the challenges we faced while studying a population-based cohort of young adults.
Methods: Wherever possible, the same questionnaire instruments were used throughout the studies. They
included questions on respiratory and allergic diseases, domestic and occupational exposure and work related
stress. Furthermore, clinical examinations including skin prick tests, spirometry and bronchial challenge with
methacholine, exhaled nitric oxide (FeNO) and blood samples were employed at baseline and 2
nd follow-up. As
information from three studies was available, multiple imputation could be used to handle missing data.
Results: Of the 3053 SOLAR I study participants who had agreed to be contacted again, about 50% had moved in
the meantime and had to be traced using phone directories and the German population registries. Overall, 2904 of
these participants could be contacted on average five years after the first follow-up. From this group, 2051 subjects
(71%) completed the questionnaire they received via mail. Of these, 57% participated at least in some parts of the
clinical examinations. Challenges faced included the high mobility of this age group. Time constraints and limited
interest in the study were substantial. Analysing the results, selection bias had to be considered as questionnaire
responders (54%) and those participating in the clinical part of the study (63%) were more likely to have a high
parental level of education compared to non-participants (42%). Similarly, a higher prevalence of parental atopy (e.
g. allergic rhinitis) at baseline was found for participants in the questionnaire part (22%) and those participating in
the clinical part of the study (27%) compared to non-participants (11%).
Conclusions: In conclusion, a 12-year follow-up from childhood to adulthood is feasible resulting in a response of
32% of the baseline population. However, our experience shows that researchers need to allocate more time to
the field work when studying young adults compared to other populations.
Background
Asthma and allergies are multi-factorial diseases with
genetic and environmental risk factors. Birth cohort stu-
dies have given important insights into risk factors in
early life contributing to these diseases during childhood
[1-5], but only few of them so far followed participants
until adulthood [4-7], and none of them took occupa-
tional risk factors into account. This might change as
current birth cohorts, recently summarized by Keil and
colleagues, reach adult age [6,7]. However, many of
these cohorts are high-risk cohorts and it is thus not
easy to extrapolate their results to the general popula-
tion [6,7].
Cohort studies starting in adulthood have shown that
occupational exposure is associated with new onset and
aggravation of respiratory and atopic diseases [8-10]. Of
these, only the European Community Respiratory Health
Survey (ECRHS) was done at the general population
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tional risk factors prospectively [8,11]. Based on this
multicentre study, the population-attributable risk of
occupational exposure for adult asthma is estimated to
be 10 to 25% [12]. However, information on childhood
disease, childhood exposure and the course of disease
over puberty is limited, because this study started at
adult age. Therefore, it is difficult to distinguish new
onset and recurrence of disease in this study.
In 2002 and 2003, we therefore conducted a first fol-
low-up of the then 16 to 18-year-old participants of the
International Study of Asthma and Allergies in Child-
hood (ISAAC) Phase Two in Munich and Dresden
[13,14].
The ISAAC Phase Two study described the regional
variation in the prevalence of atopic diseases in children
using standardized approaches that were implemented
accurately. In the first follow-up called “Study on Occu-
pational Allergy Risks (SOLAR) I”, 3785 participants of
ISAAC Phase Two completed a standardized question-
naire that included data on respiratory symptoms and
environmental exposure [15-17]. The results of this study
already indicated at this point that the occupational con-
tribution to the new onset and persistence of symptoms
during the first months of employment was considerable
[15,16,18] and that atopic teenagers did not take their
diseases into account when selecting a job [19].
At the time of the first follow-up many of the partici-
pants still attended secondary school and occupational
exposure was mainly confined to holiday jobs. Thus, a
second follow-up was planned for 2007 to 2009. This
second follow-up also included clinical examinations in
order to get in-depth information about the respiratory
health and allergic sensitization of the participants.
The aims of SOLAR II were:
￿ to describe the course of respiratory diseases and
atopy from childhood over puberty to young adult-
hood in a relatively large population-based sample;
￿ to identify environmental risk factors and their
importance for the course of respiratory and atopic
diseases;
￿ to assess the association between stress and the
course of the diseases under study;
￿ to identify occupational risk factors for the course
of these diseases.
Using the results of this study we would like to
improve career counselling in adolescents with respira-
tory or atopic diseases. Furthermore, we are interested
in identifying markers of respiratory and atopic diseases
with an onset at an early stage during vocational train-
ing, that is soon after the beginning of occupational
exposure.
This paper presents the methods and data concerning
study participation as well as non-responder analyses of
SOLAR II. The paper will help to facilitate planning and
performance of future studies investigating the natural
course of diseases in adolescent cohorts.
Methods
Study design
An overview of the study design is given in Figure 1.
Baseline study: ISAAC Phase Two
The German part of the multicentre International Study
of Asthma and Allergies in Childhood (ISAAC) Phase
Two investigated the prevalence of allergies and asthma
in grade 4 pupils (age 9-11 years) in Munich and Dres-
den in 1995-1996. Details of this study have been
described elsewhere [13,20]. Parents of 7498 children
were asked to complete a questionnaire on demo-
graphic, health and environmental factors. 85% of the
parents contacted filled in the questionnaire (table 1).
In addition, a random sample of these children was
selected and tested for asthma symptoms using spirometry
and for bronchial hyperreactivity using nebulised hyper-
tonic saline. Allergic sensitization was tested by skin prick
tests and specific IgE in blood serum. Atopic dermatitis
was assessed by standardized skin examinations.
First follow-up: SOLAR I
SOLAR I (Study on Occupational Allergy Risks I, 2002-
2003) was the first follow-up investigating ISAAC Phase
Two participants whose parents had agreed to be con-
tacted again later. At the time of the survey participants
were 16 to 18 years old. SOLAR I mainly focused on
the question whether there was an association between
starting the working life and the course of atopic and
respiratory diseases [12,21].
Overall, 4893 respondents (77%) could be re-con-
tacted. Of these, 3785 adolescents (77%) took part and
gave informed consent to combine the baseline and fol-
low-up data (table 1). The questionnaire included 118
validated items on respiratory health, allergies, preferred
j o bc h o i c e s ,s m o k i n g ,e n v i r o n m e n t a lt o b a c c os m o k e
exposure, jobs including holiday jobs and vocational
training, environmental risk factors and chronic stress.
Most items were taken from the European Community
Respiratory Health Survey( E C R H S )a n dt h eI n t e r n a -
tional Study of Asthma and Allergies in Childhood
(ISAAC) [12,21]. Wherever possible the same items as
in ISAAC Phase Two were employed. Each of the pre-
ferred job choices and of the jobs carried out so far was
coded independently by two trained coders according to
the International Standard Classification of Occupa-
tions-88 code (ISCO-88 system) (International Labour
Office 1999). Potential occupational exposure was
assigned using an asthma-specific job-exposure matrix
(JEM) [22].
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All SOLAR I participants who agreed to be re-contacted
and whose address could be traced were invited to take
part in a questionnaire study and clinical examinations
from 2007 to 2009. At that time participants were 19 to
24 years old.
All phases of the study were approved by the Ethical
Committees of the Medical Faculty of the University of
Dresden, the Bavarian Chamber of Physicians and the
University of Ulm.
Recruitment methods
All address data of participants who agreed to be re-
contacted (n = 3053) were checked first by electronic
phone directory and - if no address data could be found
(about 50%) - by the local population registries. In Ger-
many, all citizens are required by law to register their
address with the local registration office. If somebody
moves, e.g. from one town to another, the population
registry of the previous place of living receives informa-
tion about where the citizen has moved. Furthermore,
children’s current home addresses are always registered
with their parents’ addresses. This way, 95% of respon-
dents could be retraced. The remaining participants of
SOLAR I had either moved abroad or had not registered
with the local registration office.
We sent an invitation consisting of an information letter,
an informed consent form, the SOLAR II questionnaire
and an invitation to take part in the clinical examination
to the participants’ current addresses. Additionally, a ball
pen with the SOLAR logo was added to increase participa-
tion [23]. In order to ensure that the clinical examination
could be done within eight weeks after the questionnaire
response was received, 100-150 questionnaires per study
centre were sent out every month. This way, we wanted to
achieve consistency between questionnaire response and
clinical examination results. In addition, participation in
the clinical part was assumed to be higher.
In order to maximize response, non-responders
received up to two postal reminders and up to five
reminder phone calls. Those who verbally refused to
participate were asked to answer an 11-item short-ques-
tionnaire to assess selection bias and to obtain informa-
tion about their reasons for refusal.
1995/1996 2002-2003 2007-2009
ISAAC Phase Two
before entering puberty
(9-11 years)
SOLAR I
before/at start of
employment
(16-18 years)
SOLAR II
career/studies
(19-24 years)
Questionnaire
Clinical examination
Spirometry
BHR* (saline)
Skin prick test
Blood sample
Questionnaire Questionnaire
Clinical examination
Spirometry
BHR* (methacholine)
Skin prick test
Patch test
FeNO**
Blood sample
Figure 1 Flow-chart of the study. * BHR = examination of bronchial hyperresponsiveness. ** FeNO = measurement of exhaled nitric oxide.
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nation were contacted by phone within seven days after
receiving the questionnaire and were offered an appoint-
ment at the local study centre. If a phone number was
available, those who answered the questionnaire but did
not indicate participation in the clinical examination
were contacted by the local study physician and asked
for their reasons for non-participation. This way, many
people who initially did not want to participate changed
their mind after the doctor explained the procedures.
A large proportion of them initially refused, because
they lived far away from the local study centre (e.g.,
because they attended university in a different town).
They were given an appointment at the local study cen-
tre for their next visit to their home town. Others were
afraid of certain examinations (e.g. bronchial provoca-
tion) and did not know that it was possible to partici-
pate only in certain parts of the examinations.
Questionnaire instruments
The 133-item questionnaire focused on
￿ socio-demographic data (3 items)
￿ respiratory symptoms and diseases (35 items)
￿ hand eczema and atopic dermatitis (13 items)
￿ domestic exposure (17 items)
￿ smoking, environmental tobacco smoke (7 items)
￿ occupation (27 items):
◦ level of education
◦ job choice and use of occupational counselling
◦ job history for all jobs held for at least one
month and for at least eight hours a week
◦ occupational diseases
◦ occupational risk factors
￿ physical activity, body mass index (4 items)
￿ body height and weight, oral contraceptives, num-
ber of pregnancies (5 items)
￿ work related stress (TICS, Trier Inventory of the
Assessment of Chronic Stress) (22 items) [24].
Wherever possible, items identical to those employed
in SOLAR I and ISAAC Phase Two were used. In com-
parison to SOLAR I, questions concerning family status,
number of children, hand eczema and occupational
exposure to gas, fumes, cleaning agents etc. were added.
Additional items were taken from the ECRHS, the
GA
2LEN survey [25] and the TICS [24].
During the design of the SOLAR II questionnaire, the
third version of TICS already existed. Unfortunately, in
comparison to the first TICS version, which had been
used in SOLAR I, the wording of the items and the sub-
scales had changed to some extent. To guarantee com-
parability of the data with the questionnaire data of
SOLAR I, the scales “work overload” and “dissatisfac-
tion” o ft h ef i r s tv e r s i o nw e r eu s e da g a i na n dt h en e w
scale “pressure to succeed” of the third version was
added.
Table 1 Participation and reasons for non-participation in ISAAC Phase Two, SOLAR I and SOLAR II
Total Munich Dresden
n (%) n (%) n (%)
ISAAC Phase Two
Questionnaire study
6399 (85.3)
1 3354 (87.6) 3045 (83.0)
SOLAR I 3785 (77.4)
2 2043 (81.5) 1742 (73.0)
of these:
Agreed to be re-contacted 3053 (80.7) 1534 (75.1) 1519 (87.2)
SOLAR II
Drop-outs in total 149 (4.9) 85 (5.5) 64 (4.2)
Address could not be found via population registries 143 (4.7) 82 (5.3) 61 (4.0)
Deceased 6 (0.2) 3 (0.2) 3 (0.2)
Eligible study population 2904 (100.0) 1449 (100.0) 1455 (100.0)
Refusals in total 853 (29.4) 441 (30.4) 412 (28.3)
of these
Could not be reached by phone/no phone number available 454 (53.3) 184 (41.7) 270 (65.5)
Lack of interest/time 262 (30.7) 146 (33.0) 116 (28.2)
Absence from study location during the entire field phase 59 (6.9) 41 (9.3) 18 (4.4)
Other reasons 78 (9.1) 70 (15.8) 8 (1.9)
Response: questionnaire part 2051 (70.6) 1008 (69.6) 1043 (71.1)
Response: clinical study 1167 (40.2) 568 (39.2) 599 (41.2)
1 6399 of 7498 invited children
2 3785 of 4893 invited adolescents who could be re-contacted
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independently by two trained coders according to the
ISCO-88 system (International Labour Office 1999).
Afterwards an expert re-evaluation step was carried out.
Exposure to agents with potential asthma risk was
assessed by means of an asthma-specific job-exposure
matrix (JEM) [22].
Clinical examinations
Clinical examinations as described in Figure 2 were
offered to all participants. In each study centre, a team
of one study physician and one study nurse carried out
all parts of the clinical examinations. These were sched-
uled as requested by the participants. Therefore, they
were offered at various times of the day. Weekend
appointments were also offered but were not well
accepted by the participants; very few of the scheduled
participants actually showed up to their weekend
appointments. One or two days before the medical
examination the participants were contacted by phone
or per text message to remind them of their
appointment.
After the medical procedures were explained by the
study physician, the participant and the study physician
signed the informed consent form. Although the physi-
cians encouraged the participants to take part in all
parts of the examinations (Figure 2), the participants
could refuse parts of the examinations e.g. due to health
reasons such as pregnancy. Information on pregnancy
and birth was collected using the pregnancy certificate
of the participants’ mothers.
Including bronchial provocation, the clinical examina-
tions took approximately 1.5 hours per participant. At
the end of the examinations a report with all individual
results was printed and explained to the participant by
the study physician. If these results indicated pathologi-
cal findings the participants were encouraged to consult
their general practitioner. In addition, participants
received a shopping voucher as reimbursement.
At baseline (ISAAC Phase Two) and 2
nd follow-up
(SOLAR II) the clinical examinations included skin
prick tests, spirometry, bronchial challenge and blood
samples. Spirometry and bronchial hyperresponsiveness
were performed according to the ECRHS II protocol.
Medical history and explanation of the medical procedures (n=1167)
Physical examination with skin inspection (n = 1167)
Anthropometric data and first blood pressure measurement (n = 1167)
Blood sample (n = 1125)
Patch Test (n = 288)
Skin Prick Test (n = 1138)
Measurement of exhaled nitric oxide (FeNO) (n = 1156) 
Examination of bronchial hyperresponsiveness (n = 423)*
Final discussion with the study physician
Second blood pressure measurement (n = 1167) 
Spirometry (n = 1164)
Figure 2 Steps of a regular medical examination in SOLAR II. * Examination of bronchial hyperresponsiveness was only offered to 576
participants who also underwent spirometry in ISAAC Phase Two, 423 of these took part.
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chial hyperresponsiveness was performed using hyper-
t o n i cs a l i n e( 0 , 9 % )i nI S A A CP h a s eT w o .I nS O L A RI I ,
for the now adult participants, we converted to metha-
choline according to official recommendations. Skin
prick tests were performed according to the ISAAC
Phase Two protocol. In ISAAC Phase Two, total serum
IgE levels were measured using the Imulite System
(DPC Biermann, Bad Nauheim, Germany). In SOLAR II,
total serum IgE levels were measured with Fluoroenzy-
mimmunoassay using UniCAP 100 (Phadia).
Anthropometric data
Body weight and height as well as hip and waist size
were measured in all participants with calibrated instru-
ments. Additionally, blood pressure was measured with
identical automatic devices (OMRON M5-1, OMRON
HEALTHCARE Europe B.V., Hoofddorp, the Nether-
lands) in Dresden and Munich to avoid device-specific
discrepancies. Blood pressure was assessed at least once
after a defined resting period to avoid artificial hyperten-
sion. If possible, blood pressure was measured again at
the end of the examination.
Blood samples
Blood samples were collected to measure total immuno-
globulin E (IgE) and a1-antitrypsin and to perform a
multi-allergen test for occupational allergens (profes-
sional allergen mix (PAX 5) consisting of TDI, MDI and
HDI isocyanates and phthalic anhydride). Serum sam-
ples were stored at -20°C and then transferred to the
laboratory of the University Hospital of Munich (LMU)
where the analyses were performed. Additionally,
according to standardized procedures, blood samples
with anticoagulant EDTA for genetic analyses regarding
asthma-related genes were taken from those participants
who gave additional informed consent to this procedure.
Skin prick test
The skin prick tests (SPT) were conducted following the
ISAAC Phase Two protocol [20]. Exclusion criteria were
pregnancy and breast-feeding. Participants were asked
not to use any medication that could possibly affect the
result of the SPT such as antihistamines. If participants
used such medication, this was noted in the medical
database with the time of the last intake.
In ISAAC Phase Two, control solutions (histamine
and physiological saline solution
1) and extracts of com-
mon aeroallergenes (Dermatophagoides pteronyssinus
1,
D. farinae
1,c a t
1, Alternaria tenius
1, mixed grass pollen
1
and mixed tree pollen) were used. In SOLAR II, occupa-
tional allergens (rye flour
1,r a t
1,m o u s e
3, Lepidoglyphus
destructor-Lep D 1
2,t y r o p h a g u s
2,a s p e r g i l l u s
1,A l p h a -
amylase
4 and latex
4)a sw e l la sr y ep o l l e n
1 and common
ragweed
1 were added. As mixed tree pollen was out of
production, the study group decided to investigate the
three types of tree pollen (birch
1,h a z e l
1,a l d e r
1)
separately. The solutions were produced by
1ALK
Scherax (Wedel, Germany),
2Allergopharma (Reinbek,
Germany),
3Bencard Allergie (Munich, Germany) and
4Alyostal Pricktest of Stallergenes GmbH (Kamp-Lint-
fort, Germany).
The test evaluation was performed using the positive
control as reference parameter in order to avoid a possi-
ble inter- and intra-rater bias. A reaction was defined as
positive if its wheal size (average of the longest diameter
and the midway perpendicular diameter) was at least
h a l ft h es i z eo ft h ep o s i t i v econtrol [26]. SPT results
were entered into the medical database. Multiple train-
ing sessions were performed for the clinical staff to
ensure the validity and reliability as suggested by the
ISAAC Phase Two protocol [20]. This was done in
order to guarantee that the same method was applied in
both study centres.
Exhaled nitric oxide (FeNO)
The fraction of exhaled nitric oxide (FeNO) was ana-
lysed in both centres using the analyser CLD 88 sp
(ECO MEDICS AG, Duernten, Switzerland) with the
DENOX 88 device and the SPIROWARE software. The
analyser was calibrated at the beginning of each study
day. For each participant at least three FeNO levels
were recorded.
Spirometry
For the lung function measurements, participants were
asked to avoid smoking for one hour prior to the exami-
nation, refrain from ß2-agonists or anticholinergic inha-
lers for four hours before the examination and not to
use oral medications (ß2-agonists, theophylline, anti-
muscarinics) at least eight hours before the test. Partici-
pants reporting an infection of the respiratory system
within three weeks prior to the clinical examination
were re-scheduled. If this was not possible, the medica-
tion or infection was documented in the clinical
database.
Lung function was measured using the MasterScope
®
spirometer (Viasys Health Care GmbH, formerly JAE-
GER, Würzburg-Höchstadt, Version 4.53). The measure-
ments were performed and evaluated according to
American Thoracic Society criteria [27].
In short, measurements were performed in sitting
position with the subject wearing a nose clip. For each
participant at least three technically satisfactory man-
oeuvres should be recorded. If it was not possible to
obtain at least three technically satisfactory manoeuvres
after nine attempts, lung function testing was stopped.
Reference values of Quanjer et al. were used to evaluate
the results [28]. Obstruction was defined as a FEV1
value <80% predicted.
Bronchial hyperresponsiveness to methacholine
Bronchial hyperresponsiveness (BHR) was tested using
APS nebulizers (Viasys Health Care) according to the
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challenge [29,30]. The ISAAC Phase Two protocol was
not suitable for the SOLAR II age group. As mentioned
earlier, only those participants who performed a spiro-
metry in ISAAC Phase Two were asked to take part in
BHR testing in SOLAR II in order to assess the long-
term course. Doubled or quadrupled doses of methacho-
l i n ew e r eu s e du n t i lad r o pi nF E V 1 of 20% occurred.
However, in contrast to the ECRHS protocol, the maxi-
mum cumulative dose used was limited to 0.6 mg; we
have shown earlier that higher doses might lead to an
overestimation of bronchial hyperresponsiveness [31].
Skin examination and patch test
The skin of all participants was examined for atopic der-
matitis and hand eczema. Therefore, the predilection
areas in the face and the flexural folds on arms and
hands were examined in detail. If the participants
showed skin symptoms, digital photography was used
for documentation and the affected skin areas were
registered in the medical database.
Starting from November 2007, additional patch tests
were applied. The tests were conducted with the com-
m e r c i a lT R U ET e s t ™ (Mekos Laboratories ApS, Den-
mark) panels I and II consisting of 24 contact allergens
(table 2). Additionally, ten primary occupational contact
allergens (BRIAL, Greven, Germany) were tested in all
participants (table 2). Participants were asked to remove
the test layers after 48 hours and to renew the markers
that surrounded the patches in order to facilitate test
interpretation. Exclusion criteria were pregnancy, no tes-
table area of skin in the area of the upper back (e.g. due
to eczema or acne), a previous patch test or a known
contact allergy to one of the used allergens.
Skin reactions were checked only once after approx.
72 hours for feasibility reasons, as participants were not
willing to visit the study centre three times. This is com-
mon practice in many epidemiological studies. Even
with this current approach, participants often refused to
take part in the patch test due to time constraints and
the strict requirements for a successful testing (no water
on the testing area, no sports, etc. for 72 hours). The
skin reactions were labelled according to the recommen-
dations of the International Contact Dermatitis Research
Group [32]. In short, questionable and irritant reactions
were counted as negative reactions.
Quality control procedures
A pilot study was conducted in both centres with 35
young adults to evaluate the comprehensibility of the
questions and the time required to complete the ques-
tionnaire. Questions of the ISAAC Phase Two and the
SOLAR I survey were not changed to guarantee the
comparability between studies. Other questions were
adapted if the participants had difficulties understanding
their meaning.
Adherence to the study protocol was ensured through
training workshops with the field staff of the two study
centres at the beginning of and on regular basis
throughout the field phase. All technical and clinical
equipment was calibrated regularly.
Data management
Questionnaire data were entered at the data centre at
U l mU n i v e r s i t yb ya na u t o m a t i cd a t ac a p t u r es y s t e m
(Teleform Desktop V9.1 and Teleform Workgroup
V10.1, Autonomy Cardiff, Vista, CA, USA) into an MS
ACCESS database. Plain text entries were entered
manually. In addition to automatic alert, specific items
were re-evaluated by two trained data entry clerks.
Information on the recruitment of the participants and
Table 2 Allergen panels of the patch test
Panel I
1 Panel II
2 Panel III
3
Nickel sulphate Butylphenol formaldehyde resin Ammonium persulfate
Wool alcohols Paraben mix P-Toluenediamine
Neomycin sulphate Carba mix Monoethanolamine
Potassium dichromate Black rubber mix Diethanolamine
Caine mix Cl+Me-Isothiazolinone P-Aminoazobenzene
Fragrance mix Quaternium-15 N, ‘N-Methylene-bis-5-methyl-oxazolidine
Colophony Mercaptobenzothiazole Zinc-dibutyldithiocarbamate
Epoxy resin P-Phenylenediamine Glyoxal trimer (dihydrate)
Quinoline mix Formaldehyde Glutardialdehyde
Balsam of Peru Mercapto mix Bioban CS-1135
Ethylenediamine dihydrochloride Thiomersal
Cobalt chloride Thiuram mix
12TRUE Test™ (Mekos Laboratories ApS, Denmark)
³ BRIAL, Greven, Germany
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were entered into MS ACCESS databases. The resulting
data-sets were merged to the previous studies (ISAAC
Phase Two and SOLAR I) using a unique identifier.
Data quality was checked routinely and included global
checks on participant mismatches from various data
sources and plausibility checks.
Imputation of missing data
Missing data were assumed to be missing at random
(MAR), thus allowing for application of multiple impu-
tation [33]. Two different methods were used for the
imputation of five respective data sets:
a) using the AMELIA II package in R
b) drawing from the empirical distribution of the
variables of interest.
In both cases, imputation was restricted to missing
exposure and confounding questionnaire data. 98% of
the variables imputed had a low missingness of less than
14% (range 0.1%-21.9%) of the data.
Statistical analyses
Initially, data were analysed descriptively. Bivariate associa-
tions between potential confounders and outcomes were
assessed as well as possible bivariate associations between
exposure and outcomes. Furthermore, longitudinal statisti-
cal models concerning different aspects of occupational
exposure and diseases were fitted. We analysed whether
pre-existing symptoms had influenced the job choice of
the participants. Moreover, individual risk factors and
probabilities for the incidence of occupational asthma and
allergies in certain job groups were estimated. The latency
period between start of (occupational) exposure and the
first symptoms was taken into account when reconsidering
the best time for a follow-up.
Non-responder analyses
To evaluate potential selection bias, ISAAC Phase Two
results were compared for three groups of participants:
￿ Group 1: people who participated only in the
ISAAC Phase Two questionnaire survey
￿ Group 2: people who participated in the ISAAC
Phase Two and SOLAR I, but not in SOLAR II
￿ Group 3: people who participated in the ISAAC
Phase Two, SOLAR I and SOLAR II questionnaire
survey
Results
Participation
Overall, 3053 young adults were contacted and asked to
participate in SOLAR II. For 143 people no recent home
address could be obtained from the population regis-
tries, six people had died. Therefore, 2904 people were
eligible for the study. 2051 people (71% of the eligible
sample) answered the questionnaire (table 1).
853 of the remaining participants of SOLAR I (29% of
the eligible sample) refusedt ot a k ep a r ti nS O L A RI I .
The most frequent reason for non-participation was that
the subjects did not answer the invitation letter, that no
telephone number was available or they could not be
reached by phone (455 people; 53%) (table 1). Only 30
of the non-responders were willing to fill in the short
non-responder questionnaire.
In Munich, 56% and in Dresden 57% of those who
completed the SOLAR II questionnaire took part in the
clinical examinations (40% of the eligible sample) (table
1). Of the 884 participants (30% of the eligible sample)
who filled in the questionnaire but refused to take part
in the clinical examinations, 26% did not want to parti-
cipate due to lack of interest and 19% due to time con-
straints. A further 12% no longer lived close to the
study centres and thus felt unable to participate.
Non-responder analyses
ISAAC Phase Two results were compared for three
groups of participants. Children of parents with higher
socio-economic status were more likely to participate in
the follow-up studies. In addition, respiratory symptoms
or disease in ISAAC Phase Two and parental atopy as
well as the lack of passive smoke exposure during child-
hood and no smoking of the mother during pregnancy
were predictors for participation in SOLAR I and II
(table 3).
Participants with a higher level of education, students,
people with a higher parental educational level and par-
ticipants in occupations with high-risk exposure of
asthma were more likely to participate in the clinical
examinations. Smokers and people with regularly passive
smoke exposure were less motivated. However, partici-
pation in the clinical examination was independent of
parental atopy, respiratory symptoms of the young
adults or a current occupation in the health care sector
(table 4).
Discussion
We are presenting the study design and the first results
of a prospective population-based cohort study investi-
gating atopic and respiratory diseases among young
adults in Germany aged 19 to 24 years today. The main
focus of SOLAR II is on the association between occu-
pational exposure and the course of atopic and respira-
tory diseases.
One of the strengths of this study is its adequate sam-
ple size with follow-up data for over 2000 young adults
a n dt h ef o l l o w - u pp e r i o do fm o r et h a n1 2y e a r s .
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detailed information about job history, occupational
exposure and persistence, recurrence or new-onset of
atopic diseases could be assessed.
Furthermore, multiple imputation could be used to
handle missing data due to the availability of informa-
tion from three studies. In addition, data from ISAAC
Phase Two and SOLAR I make it possible to estimate
selection bias in the analyses.
Another advantage of SOLAR II is the detailed assess-
ment of a number of exposure and diseases using stan-
dardized and validated protocols for the questionnaire
and the clinical examination [20] as well implementing
a quality control. Additionally, several arrangements
were made to increase participation as far as possible
and to decrease selection bias. These arrangements
included postal reminders, up to five telephone calls,
text messages as reminders of the clinical examinations,
flexible examination hours and shopping vouchers for
participation in the clinical examination.
Investigating the age group of young people and young
adults, it’s important also to use the “new” communication
technologies which are very popular among these age
Table 3 Non-responder analysis: Descriptive results and
prevalence of atopic diseases, data taken from ISAAC
Phase Two.
%
95% CI
1
Group 1
2
(n = 2581)
Group 2
3
(n = 1767)
Group 3
4
(n = 2051)
Female 55.0
53.1; 56.9
53.8
51.5; 56.1
58.1
56.0; 60.3
High parental level of education
5 41.5
39.5; 43.5
47.1
44.7; 49.4
58.9
56.7; 61.0
Smoking during pregnancy 13.5
11.9; 15.1
9.8
8.3; 11.4
5.9
4.8; 7.0
Passive smoke exposure 50.3
48.3; 52.4
47.3
44.9; 49.7
36.4
34.3; 38.5
Current wheeze
6 6.9
5.9; 7.9
9.5
8.1; 10.8
8.2
7.0; 9.4
Doctor diagnosed asthma 3.3
2.6; 4.0
4.5
3.5; 5.5
3.4
2.6; 4.2
Current allergic rhinitis
7 11.1
9.8; 12.3
14.1
12.4; 15.7
14.4
12.8; 15.9
Current atopic dermatitis
8 11.6
10.4; 12.9
13.2
11.6; 14.8
15.2
13.6; 16.7
Specific IgE > 0.7 kU/L 28.7
26.0; 31.3
34.8
32.1; 37.4
33.4
31.0; 35.7
Positive skin prick test 23.2
21.0; 25.5
24.5
22.3; 26.7
23.6
21.7; 25.6
Bronchial hyperreactivity 14.7
11.9; 17.4
19.5
16.5; 22.4
17.3
14.8; 19.8
Parental allergic disease
9 36.2
34.3; 38.1
40.9
38.6; 43.3
46.2
44.0; 48.3
1 95% CI: 95% Confidence Interval
2 group 1: people who participated only in ISAAC Phase Two
3 group 2: people who participated in ISAAC Phase Two and SOLAR I
4 group 3: people who participated in SOLAR II (without the people of group
1 and 2)
5 at least one parent with a minimum of 12 years of education
6 wheezing in the last 12 months
7 problems with sneezing or a runny or blocked nose (without having a cold)
accompanied by itchy-
watery eyes in the last 12 months
8 itching eczema in the last 12 months persisting at least 6 months
9 asthma, allergic rhinitis or atopic dermatitis
bold: statistically significant differences between groups
Table 4 Non-responder analysis: SOLAR II questionnaire
data compared for participants of the questionnaire part
and the clinical part of the study
%
95% CI
1
Questionnaire
part only
(n = 884)
Questionnaire and
clinical part
(n = 1167)
Female 56.3
53.1; 59.6
59.5
56.6; 62.3
High level of education
2 52.5
49.1; 55.8
70.0
67.4; 72.7
High parental level of
education
3
54.2
50.8; 57.5
62.4
59.6; 65.2
Student 36.3
33.1; 39.4
50.5
47.6;53.3
Current occupation: health
care sector
13.1
10.9; 15.4
14.7
12.7; 16.8
Smoker 44.0
40.7; 47.3
32.0
29.3; 34.7
Passive smoke exposure
(regularly)
63.3
60.1; 66.5
51.5
48.6;54.3
Job with high-risk
exposure
4
25.8
22.5;29.2
32.3
29.2; 35.3
Job with low-risk
exposure
4
23.0
19.8; 26.2
19.9
17.3; 22.5
Job without risk
exposure
4
36.3
32.6; 39.9
39.7
36.5; 42.8
Current wheeze
5 16.3
13.9; 18.8
17.2
15.1; 19.4
Doctor diagnosed asthma 8.3
6.4; 10.1
9.3
7.6; 10.9
Current allergic rhinitis
6 22.1
19.3; 24.9
27.0
24.4; 29.5
Current atopic dermatitis
7 11.3
9.2; 13.4
13.1
11.1; 15.0
Parental allergic disease
8 42.9
39.7; 46.2
48.6
45.7; 51.5
1 95% CI: 95% Confidence Interval
2 at least 12 years of education
3 at least one parent with a minimum of 12 years of education
4 exposure to agents with potential asthma risk was assessed by means of an
asthma-specific job-
exposure matrix (JEM)
5 wheezing in the last 12 months
6 problems with sneezing or a runny or blocked nose (without having a cold)
accompanied by itchy-
watery eyes in the last 12 months
7 itching eczema in the last 12 months persisting at least 6 months
8 asthma, allergic rhinitis or atopic dermatitis
bold: statistically significant differences between groups
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Page 9 of 11groups. One or two days before the medical examination
the participants were contacted by phone or per text mes-
sage as reminder of their fixed date. We also collected the
email addresses of the participants to send them a route
description (if they took part in the medical examination)
and a message concerning the main results of the study.
Therefore, if a third follow-up study would take place, it
would be possible to use an online questionnaire.
Selection bias had to be considered in the result ana-
lyses, as females and children of parents with higher
socio-economic status were more likely to participate in
the follow-up studies. This issue had already arisen dur-
ing SOLAR I. In addition, parental atopy and respiratory
symptoms or disease in ISAAC Phase Two were predic-
tors of participation in SOLAR I and II. People without
passive smoke exposure during childhood and partici-
pants whose mothers didn’t smoke during pregnancy
were also more likely to participate in the follow-up stu-
dies. Probably, children of health conscious parents are
more motivated to participate.
Therefore, a selection towards higher educated partici-
pants with higher likelihood of atopic diseases can be
assumed. The higher level of education might lead to
lower risk of occupational exposure. This may result in
a selection bias if participation was differential with
respect to exposure and disease. I.e., if participants with
higher exposure were more likely to be symptomatic
while those with lower exposure were less likely to be
symptomatic, an overestimation of the true risk may
result. This needs to be taken into consideration when
interpreting the results.
Concerning the interpretation of the results of the
clinical examination of SOLAR II, it should be consid-
ered that participants with a higher level of education,
students, people with a high parental education level
and people in occupations with high-risk exposure of
asthma were more likely to participate. Presumably, stu-
dents had less time problems due to their flexible time-
table and long semester breaks as well as a higher inter-
est to take part in a scientific study. The number of
smokers and people with regularly passive smoke expo-
sure was higher among the participants who only filled
in the questionnaire.
Conclusions
In conclusion, a 12-year follow-up from childhood to
adulthood is feasible resulting in a response of 32% of
the baseline population. However, our experience shows
that researchers need to allocate more time to the field
work when studying young adults compared to other
populations. For example, about 50% of the participants’
addresses needed to be checked by the local population
registries. Furthermore, postal reminders, reminder
phone calls and in some cases second or even third
appointments for the clinical examination were neces-
sary to achieve adequate response. These results could
be helpful for birth cohorts that now reach adulthood.
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